Treatment with neutralizing antibodies specific for IL-1β prevents cyclophosphamide-induced diabetes in nonobese diabetic mice

Diabetes

Volumn 46, Issue 6, 1997, Pages 937-940

  Cailleau, Catherine ^a,b   Diu Hercend, Anita ^b   Ruuth, Erik ^b   Westwood, Robert ^b   Carnaud, Claude ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; PRIORITY JOURNAL;

EID: 0030995686     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.6.937     Document Type: Article

References (31)

1. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996
2. Dinarello CA: Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol 3:941-948, 1991
3. Mandrup-Poulsen T, Helqvist S, Molvig J, Wogensen LD, Nerup J: Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 4:191-218, 1989
4. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N: Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells. Autoimmunity 10:241-253, 1991
5. Dayer-Metroz MD, Duhamel D, Rufer N, Izui S, Carmichaels D, Wollheim CB, Thompson RC, Dayer JM: IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats (Abstract). Eur J Clin Invest 22:A50, 1992
6. Nicoletti F, Dimarco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P: Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 24:1843-1847, 1994
7. Lomedico PT, Gubler U, Hellmann CP: Cloning and expression of murine interleukine-1 cDNA in Escherichia coli. Nature 312:458-462, 1984
8. Minnich-Carruth LL, Suttles J, Mizel SB: Evidence against the existence of a membrane form of murine IL-1 alpha J Immunol 142:526-530, 1989
9. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Cordon PJ, Cosman D, Hopp TP, Mochizuki DY: Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263:9437-9442, 1988
10. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain XA, Schmidt JA: Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 86:5227-5231, 1989
11. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei FY, Wong W, Kamen R, Seshadri T: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401-411, 1995
12. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MSS, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003, 1995
13. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M: Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545-1547, 1986
14. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 87:968-972, 1990
15. Wilson CA, Jacobs C, Baker P, Baskin DG, Dower SK, Lernmark A, Tivola B, Vertrees S, Wilson D: IL-I beta modulation of autoimmune diabetes and thyroiditis in the BB rat. J Immunol 144:3784-3788, 1990
16. Högquist KA, Nett MA, Sheehan KCF, Pendleton KD, Schreiber RD, Chaplin DD: Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo. J Immunol 146:1534-1540, 1991
17. Kaye J, Gillis S, Mizel SB, Shevach EM, Malek TR, Dinarello CA, Lachman LB, Janeway CA: Growth of a cloned helper T cell line induced by monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol 133:1339-1345, 1984
18. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide. Diabetes 37:930-935, 1988
19. Yasunami R, Bach JF: Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18:481-484, 1988
20. Wicker LS, Todd JA, Peterson LB: Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200, 1995
21. Sereze DV, Leiter EH: Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immunol 140:3801-3807, 1988
22. Debray-Sach M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach JF: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 4:237-248, 1991
23. Campbell IL, Oxbrow L, Koulmanda M, Harrison LC: IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol 140:1111-1116, 1988
24. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136-4150, 1993
25. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassali JD, Vassali P: Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1731, 1992
26. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, McDevitt HO: Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. 1. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995-1004, 1994
27. 26a. Hunger RG, Carnaud C, Garcia I, Vassalli P, Mueller C: Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur J Immunol 27:255-261, 1997
28. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L: Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821, 1995
29. Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA, Flavell RA: Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells. J Exp Med 184:1963-1974, 1996
30. Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon JW: Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol 152:2042-2050, 1994
31. Wang L, Miura M, Bergeron L, Zhu H, Yuan Y: Ich-1, an Ice/ced3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-750, 1994